The right exercise approach can boost GLP-1 medication results by 30-40%. Strength training prevents muscle loss, while strategic cardio accelerates fat burning without overwhelming your…
Read full guide →Up to 20% of patients see minimal weight loss on GLP-1 medications. Genetic factors, medication interactions, and individual biology determine who responds well to these…
Read full guide →Foundayo hit the market in April 2026 as the first non-peptide GLP-1 pill without food restrictions. Unlike other oral weight loss medications, you can take…
Read full guide →GLP-1 medications now carry FDA approval for reducing major cardiovascular events, not just weight loss. The SELECT trial results changed how doctors prescribe these medications…
Read full guide →"Ozempic face" describes facial aging that can occur during rapid weight loss on GLP-1 medications. This cosmetic side effect results from volume loss in facial…
Read full guide →Retatrutide represents the next frontier in obesity treatment. This investigational triple-receptor agonist from Eli Lilly targets GLP-1, GIP, and glucagon receptors simultaneously, delivering unprecedented weight…
Read full guide →The FDA approved Wegovy 7.2mg in March 2026, marking the highest-dose semaglutide treatment available for weight management. This new formulation delivers unprecedented weight loss results…
Read full guide →Yes, most patients can take GLP-1 medications long term. Obesity is a chronic medical condition requiring ongoing treatment, similar to diabetes or high blood pressure.…
Read full guide →GLP-1 medications don't directly cause hair loss, but rapid weight loss can trigger telogen effluvium—temporary hair thinning that affects 10-25% of patients. This usually resolves…
Read full guide →The Wegovy pill costs $149 per month through April 15, 2026, as part of Novo Nordisk's launch pricing. After that, the regular price is $199…
Read full guide →